Loading data
RZLTNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 53.8 m USD | 61.53 m USD | 55.74 m USD | 43.81 m USD | 32.49 m USD |
| Operating profit | -82.97 m USD | -79.89 m USD | -70.42 m USD | -55.99 m USD | -41.84 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -77.59 m USD | -74.41 m USD | -68.46 m USD | -51.79 m USD | -41.06 m USD |
| Net income attributable to common shareholders | -77.59 m USD | -74.41 m USD | -68.46 m USD | -51.79 m USD | -41.06 m USD |
| Basic earnings per share | -0.75 USD/share | -0.98 USD/share | -1.33 USD/share | -1.01 USD/share | -2.26 USD/share |
| Diluted earnings per share | -0.75 USD/share | -0.98 USD/share | -1.33 USD/share | -1.01 USD/share | -2.32 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.